Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Konson Konjac Gum Co., Ltd. is a leading global manufacturer specializing in the research, development, and production of konjac-based products, including konjac gum and glucomannan. The company serves the food, pharmaceutical, and healthcare industries, providing high-purity dietary fibers used for weight management, blood sugar regulation, and cholesterol reduction. Konson Konjac operates advanced manufacturing facilities and holds numerous international certifications such as ISO, HALAL, and KOSHER. Their products are also utilized as pharmaceutical excipients for controlled-release drug delivery and capsule production. Based in Wuhan, China, the company has established a significant presence in the international market for natural hydrocolloids and functional ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Konson Konjac.